PRESS RELEASE published on 05/08/2026 at 19:12, 3 months 2 days ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026 Viromed Medical AG missed revenue forecast for 2025 but saw significant growth, achieving a positive result. The company has revised its forecast for 2026 due to market launch delays Revenue Forecast Growth Viromed Medical AG Forecast Revision Positive Result
BRIEF published on 04/21/2026 at 09:17, 3 months 19 days ago Viromed Medical AG commence la production de ViroCAP® pour HELLMUT RUCK GmbH Viromed Medical AG Technologie Du Plasma Froid ViroCAP® HELLMUT RUCK GmbH Marché De La Podologie
BRIEF published on 04/21/2026 at 09:17, 3 months 19 days ago Viromed Medical AG Begins Production of ViroCAP® for HELLMUT RUCK GmbH Viromed Medical AG Cold Plasma Technology ViroCAP® HELLMUT RUCK GmbH Podiatry Market
PRESS RELEASE published on 04/21/2026 at 09:12, 3 months 19 days ago Viromed Medical AG starts production of the OEM version of ViroCAP® for HELLMUT RUCK GmbH Viromed Medical AG starts production of the OEM version of ViroCAP® for HELLMUT RUCK GmbH, marking an exclusive partnership in podiatry with access to over 120,000 customers and preparations for further international sales cooperations Partnership Podiatry Viromed Medical AG ViroCAP OEM Version
BRIEF published on 03/23/2026 at 11:49, 4 months 18 days ago Viromed Medical AG obtient un financement pour ses innovations dans le domaine du plasma froid Viromed Medical AG Technologie Du Plasma Froid Innovation En Médecine Financement Du Ministère Fédéral Développement De PulmoPlas®
BRIEF published on 03/23/2026 at 11:49, 4 months 18 days ago Viromed Medical AG Secures Funding for Cold Plasma Innovations Viromed Medical AG Cold Plasma Technology Innovation In Medicine Federal Ministry Funding PulmoPlas® Development
PRESS RELEASE published on 03/23/2026 at 11:44, 4 months 18 days ago Viromed Medical AG receives funding approval from the Federal Ministry of Research, Technology and Space for the development of cold plasma technology Viromed Medical AG receives funding approval from the Federal Ministry of Research, Technology and Space for the development of cold plasma technology Research And Development Viromed Medical AG Scientific Innovation Cold Plasma Technology Funding Approval
BRIEF published on 03/19/2026 at 09:05, 4 months 22 days ago Viromed Medical AG Appoints Anna Heinen to Supervisory Board Supervisory Board Corporate Strategy Viromed Medical AG Cold Plasma Technology Anna Heinen
BRIEF published on 03/19/2026 at 09:05, 4 months 22 days ago Viromed Medical AG nomme Anna Heinen au conseil de surveillance Stratégie D'entreprise Conseil De Surveillance Viromed Medical AG Technologie Du Plasma Froid Anna Heinen
PRESS RELEASE published on 03/19/2026 at 09:00, 4 months 22 days ago Viromed Medical AG: Anna Heinen appointed to the Supervisory Board Anna Heinen appointed to the Supervisory Board of Viromed Medical AG, bringing expertise in corporate strategy and governance. She succeeds Frank Otto Governance Supervisory Board Corporate Strategy Viromed Medical AG Anna Heinen
Published on 08/10/2026 at 20:30, 48 minutes ago Clean Air Metals and Fiore-backed Springbok Ventures Announce Upsize of Non-Brokered Private Placement
Published on 08/10/2026 at 15:30, 5 hours 48 minutes ago Silver Spruce Resources, Inc. Announces New Chief Financial Officer
Published on 08/10/2026 at 15:25, 5 hours 53 minutes ago Gemdale Gold Intersects 5.19m at 14.01 g/t Au within 110m at 1.18 g/t Au at the Pontio Gold Project, Finland
Published on 08/10/2026 at 14:30, 6 hours 48 minutes ago NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak
Published on 08/10/2026 at 13:30, 7 hours 48 minutes ago Sterling Expands High-Grade Copper Mineralization East at MEPS Intersecting 203 Metres at 0.51% CuEq: Includes 16.25 Metres at 2.31% CuEq and 9.50 Metres at 2.34% CuEq within 445 Metres at 0.40% CuEq
Published on 08/10/2026 at 19:35, 1 hour 43 minutes ago Kontron AG: All conditions of the mandatory tender offer of Ennoconn Corporation are met – Settlement will take place shortly
Published on 08/10/2026 at 19:00, 2 hours 18 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 03 AOUT 2026 au 07 AOUT 2026
Published on 08/10/2026 at 18:29, 2 hours 48 minutes ago Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Published on 08/10/2026 at 17:50, 3 hours 28 minutes ago Disclosure according to Article 5(1)(b) of the EU Regulation No. 596/2014 and Article 2(3) of the Delegated EU Regulation No. 2016/1052 - 1st Interim Report
Published on 08/10/2026 at 18:00, 3 hours 18 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 3 hours 18 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 3 hours 33 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 08/10/2026 at 11:53, 9 hours 24 minutes ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026